论文部分内容阅读
目的观察普米克令舒,沐舒坦,庆大霉素联合氧气驱动雾化吸入防治早产儿肺透明膜病的疗效。方法分治疗组与对照组,治疗组为我院2005年6月至2009年6月收治的胎龄29～35周的早产儿46例在生后4h内使用普米克令舒,沐舒坦,庆大霉素联合氧气驱动雾化吸入,对照组为2003年1月至2005年6月我院收治的未使用雾化吸入的条件相同的早产儿45例。结果治疗组46例出现肺透明膜病2例,对照组45例出现肺透明膜病8例。结论普米克,沐舒坦,庆大霉素联合防治早产儿肺透明膜病疗效满意,方法简便,值得在基层医院推广。
Objective To observe the efficacy of pulmicort respules, mucosolvan, gentamycin and oxygen-driven nebulization in the prevention and treatment of hyaline membrane disease in preterm infants. Methods The treatment group and the control group, the treatment group for our hospital from June 2005 to June 2009 were admitted to the gestational age of 29 to 35 weeks of 46 preterm infants within 4h after birth with pulmicort, mucosolvan, Qing The combination of gentamicin and oxygen inhalation inhalation, the control group was January 2003 to June 2005 admitted to our hospital without the use of inhalation of the same conditions of preterm infants 45 cases. Results There were 2 cases of hyaline membrane disease in 46 cases and 8 cases of hyaline membrane disease in 45 cases in control group. Conclusion Pulmicort, mucosolvan, gentamicin combined with prevention and treatment of premature children with hyaline membrane disease, satisfactory results, the method is simple, it is worth promoting in primary hospitals.